Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Kobinger GP"'
Autor:
Kobinger GP, Leung A, Neufeld J, Richardson JS, Falzarano D, Smith G, Tierney K, Patel A, Weingartl HM
Publikováno v:
Journal of Infectious Diseases; 2011, Vol. 204 Issue 2, p200-208, 9p
Autor:
de La Vega MA; Département de microbiologie-infectiologie et d'immunologie, Université Laval, Québec, Québec, Canada., Wong G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba,Canada., Wei H; Institute of Infectious Disease, Henan Center for Disease Control and Prevention, Zhengzhou, Henan, China., He S; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba,Canada., Bello A; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba,Canada., Fausther-Bovendo H; Département de microbiologie-infectiologie et d'immunologie, Université Laval, Québec, Québec, Canada., Audet J; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba,Canada., Tierney K; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba,Canada., Tran K; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba,Canada., Soule G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba,Canada., Racine T; Vaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Strong JE; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba,Canada., Qiu X; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba,Canada., Kobinger GP; Département de microbiologie-infectiologie et d'immunologie, Université Laval, Québec, Québec, Canada.; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania,USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2022 Sep 04; Vol. 226 (4), pp. 616-624.
Autor:
Fausther-Bovendo H; Department of Microbiology and Immunology, Faculty of Medicine, Laval University, Quebec, Canada., Qiu X; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada., Babuadze GG; Department of Microbiology and Immunology, Faculty of Medicine, Laval University, Quebec, Canada., Azizi H; Department of Microbiology and Immunology, Faculty of Medicine, Laval University, Quebec, Canada., Pedersen J; Department of Microbiology and Immunology, Faculty of Medicine, Laval University, Quebec, Canada., Wong G; Department of Microbiology and Immunology, Faculty of Medicine, Laval University, Quebec, Canada.; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Canada., Kobinger GP; Department of Microbiology and Immunology, Faculty of Medicine, Laval University, Quebec, Canada.; Department of Pathology and Laboratory Medicine, University of Pennsylvania School 27 of Medicine, Philadelphia, Pennsylvania, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2022 May 16; Vol. 225 (10), pp. 1852-1855.
Autor:
Nsio J; Ministry of Health, Kinshasa, Democratic Republic of the Congo., Kapetshi J; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo., Makiala S; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo., Raymond F; Universite Laval, Quebec City, Canada., Tshapenda G; Ministry of Health, Kinshasa, Democratic Republic of the Congo., Boucher N; Universite Laval, Quebec City, Canada., Corbeil J; Universite Laval, Quebec City, Canada., Okitandjate A; Ministry of Health, Kinshasa, Democratic Republic of the Congo., Mbuyi G; Ministry of Health, Kinshasa, Democratic Republic of the Congo., Kiyele M; Ministry of Health, Kinshasa, Democratic Republic of the Congo., Mondonge V; World Health Organization (WHO), Kinshasa, Democratic Republic of the Congo., Kikoo MJ; World Health Organization (WHO), Kinshasa, Democratic Republic of the Congo., Van Herp M; Médecins sans Frontières (MSF), Geneva, Switzerland., Barboza P; WHO, Geneva, Switzerland., Petrucci R; Médecins sans Frontières (MSF), Geneva, Switzerland., Benedetti G; Medical Department, Operational Centre-Brussels, MSF, Luxembourg, Luxembourg., Formenty P; WHO, Geneva, Switzerland., Muyembe Muzinga B; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo., Ilunga Kalenga O; Ministry of Health, Kinshasa, Democratic Republic of the Congo., Ahuka S; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo., Fausther-Bovendo H; Universite Laval, Quebec City, Canada., Ilunga BK; Ministry of Health, Kinshasa, Democratic Republic of the Congo., Kobinger GP; Universite Laval, Quebec City, Canada., Muyembe JT; Institut National de Recherche Biomedicale, Kinshasa, Democratic Republic of the Congo.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2020 Feb 18; Vol. 221 (5), pp. 701-706.
Autor:
Tebas P; University of Pennsylvania, Philadelphia., Kraynyak KA; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Patel A; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Maslow JN; GeneOne Life Science, Gangnam-Gu, Seoul, Korea., Morrow MP; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Sylvester AJ; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Knoblock D; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Gillespie E; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Amante D; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Racine T; Université Laval, Quebec City, Quebec, Canada., McMullan T; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Jeong M; GeneOne Life Science, Gangnam-Gu, Seoul, Korea., Roberts CC; GeneOne Life Science, Gangnam-Gu, Seoul, Korea., Park YK; GeneOne Life Science, Gangnam-Gu, Seoul, Korea., Boyer J; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Broderick KE; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Kobinger GP; Université Laval, Quebec City, Quebec, Canada., Bagarazzi M; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., Weiner DB; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Sardesai NY; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania., White SM; Inovio Pharmaceuticals, Plymouth Meeting, Pennsylvania.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2019 Jul 02; Vol. 220 (3), pp. 400-410.
Autor:
Patel A; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Reuschel EL; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Kraynyak KA; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Racine T; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., Park DH; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Scott VL; College of Osteopathic Medicine, William Carey University, Hattiesburg, Mississippi., Audet J; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., Amante D; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Wise MC; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Keaton AA; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Wong G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Villarreal DO; University of Pennsylvania, Philadelphia., Walters J; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Muthumani K; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania., Shedlock DJ; University of Pennsylvania, Philadelphia., de La Vega MA; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Plyler R; University of Pennsylvania, Philadelphia., Boyer J; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Broderick KE; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Yan J; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Khan AS; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Jones S; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Bello A; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Soule G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Tran KN; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., He S; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Tierney K; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Qiu X; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., Kobinger GP; University of Pennsylvania, Philadelphia.; Université Laval, Québec, Canada., Sardesai NY; Inovio Pharmaceuticals Inc., Plymouth Meeting, Pennsylvania., Weiner DB; The Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2019 Jan 29; Vol. 219 (4), pp. 544-555.
Autor:
de La Vega MA; Département de Microbiologie-Infectiologie et d'Immunologie, Université Laval, Québec, Canada.; Centre de Recherche en Infectiologie du CHU de Québec - Université Laval, Canada., Piret J; Centre de Recherche en Infectiologie du CHU de Québec - Université Laval, Canada., Griffin BD; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., Rhéaume C; Centre de Recherche en Infectiologie du CHU de Québec - Université Laval, Canada., Venable MC; Centre de Recherche en Infectiologie du CHU de Québec - Université Laval, Canada., Carbonneau J; Centre de Recherche en Infectiologie du CHU de Québec - Université Laval, Canada., Couture C; Département d'Anatomo-Pathologie, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Canada.; Département de Biologie Moléculaire, Biochimie Médicale et Pathologie, Université Laval, Québec, Canada., das Neves Almeida R; Laboratory of Immunology and Inflammation, University of Brasilia, Brazil., Tremblay RR; Unité de Recherche en Reproduction, Santé de la Mère et de l'Enfant, Centre de Recherche du CHU de Québec - Université Laval, Canada., Magalhães KG; Laboratory of Immunology and Inflammation, University of Brasilia, Brazil., Park YK; GeneOne Life Science Inc., Seoul, Korea., Roberts CC; GeneOne Life Science Inc., Seoul, Korea., Maslow JN; GeneOne Life Science Inc., Seoul, Korea.; Department of Medicine, Morristown Medical Center, New Jersey., Sardesai NY; Inovio Pharmaceuticals, Inc., Plymouth Meeting, Pennsylvania., Kim JJ; Inovio Pharmaceuticals, Inc., Plymouth Meeting, Pennsylvania., Muthumani K; The Wistar Institute, Philadelphia, Pennsylvania., Weiner DB; The Wistar Institute, Philadelphia, Pennsylvania., Kobinger GP; Département de Microbiologie-Infectiologie et d'Immunologie, Université Laval, Québec, Canada.; Centre de Recherche en Infectiologie du CHU de Québec - Université Laval, Canada.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.; Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia., Boivin G; Département de Microbiologie-Infectiologie et d'Immunologie, Université Laval, Québec, Canada.; Centre de Recherche en Infectiologie du CHU de Québec - Université Laval, Canada.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2019 Jan 09; Vol. 219 (3), pp. 365-374.
Autor:
Wong G; Special Pathogens Program, Public Health Agency of Canada, Winnipeg, Manitoba.; Guangdong Key Laboratory for Diagnosis and Treatment of Emerging Infectious Diseases, Shenzhen Third People's Hospital, China.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China., Leung A; Special Pathogens Program, Public Health Agency of Canada, Winnipeg, Manitoba.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., He S; Special Pathogens Program, Public Health Agency of Canada, Winnipeg, Manitoba., Cao W; Special Pathogens Program, Public Health Agency of Canada, Winnipeg, Manitoba.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., De La Vega MA; Département de Microbiologie-Infectiologie et d'Immunologie, Université Laval, Quebec City, Canada., Griffin BD; Special Pathogens Program, Public Health Agency of Canada, Winnipeg, Manitoba.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., Soule G; Special Pathogens Program, Public Health Agency of Canada, Winnipeg, Manitoba., Kobinger GP; Département de Microbiologie-Infectiologie et d'Immunologie, Université Laval, Quebec City, Canada., Kobasa D; Special Pathogens Program, Public Health Agency of Canada, Winnipeg, Manitoba.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada., Qiu X; Special Pathogens Program, Public Health Agency of Canada, Winnipeg, Manitoba.; Department of Medical Microbiology, University of Manitoba, Winnipeg, Canada.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2018 Nov 22; Vol. 218 (suppl_5), pp. S466-S470.
Autor:
Warfield KL; Integrated BioTherapeutics Inc., Rockville, Maryland., Howell KA; Integrated BioTherapeutics Inc., Rockville, Maryland., Vu H; Integrated BioTherapeutics Inc., Rockville, Maryland., Geisbert J; University of Texas Medical Branch, Galveston., Wong G; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba., Shulenin S; Integrated BioTherapeutics Inc., Rockville, Maryland., Sproule S; Optimum Statistics Inc., Winnipeg, Manitoba, Canada., Holtsberg FW; Integrated BioTherapeutics Inc., Rockville, Maryland., Leung DW; Departments of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri., Amarasinghe GK; Departments of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri., Swenson DL; US Army Medical Research Institute of Infectious Diseases, Frederick, Maryland., Bavari S; US Army Medical Research Institute of Infectious Diseases, Frederick, Maryland., Kobinger GP; Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba., Geisbert TW; University of Texas Medical Branch, Galveston., Aman MJ; Integrated BioTherapeutics Inc., Rockville, Maryland.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2018 Nov 22; Vol. 218 (suppl_5), pp. S553-S564.
Autor:
Kapetshi J; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.; University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Fausther-Bovendo H; Laval University, Quebec, Quebec., Corbett C; Public Health Agency of Canada, Winnipeg, Manitoba., Leung A; Public Health Agency of Canada, Winnipeg, Manitoba., Ait-Ikhlef K; World Health Organization, Emerging and Dangerous Pathogens Laboratory Network, Geneva, Switzerland., Nsio J; Heath Ministry, Kinshasa, Democratic Republic of the Congo., Aruna A; Heath Ministry, Kinshasa, Democratic Republic of the Congo., Kebela Ilunga B; Heath Ministry, Kinshasa, Democratic Republic of the Congo., Muyembe JJ; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.; University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Formenty P; Heath Ministry, Kinshasa, Democratic Republic of the Congo., Kobinger GP; Laval University, Quebec, Quebec.; University of Pennsylvania School, Philadelphia.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2018 Nov 22; Vol. 218 (suppl_5), pp. S292-S296.